Vascularization pattern after ischemic stroke is different in control versus diabetic rats relevance to stroke recovery

Stroke

Volumn 44, Issue 10, 2013, Pages 2875-2882

  Prakash, Roshini ^a,b   Li, Weiguo ^a,c   Qu, Zhi ^c   Johnson, Maribeth A ^d   Fagan, Susan C ^a,b   Ergul, Adviye ^a,b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

^d AUGUSTA UNIVERSITY   (United States)

Author keywords

Animal behavior; Astrocytes; Diabetes mellitus; Metformin; Neovascularization; Recovery; Type 2

Indexed keywords

FLUORESCEIN ISOTHIOCYANATE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUCOSE; METFORMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY DISORDER; ARTICLE; ASTROCYTOSIS; BRAIN BLOOD VESSEL; BRAIN ISCHEMIA; CELL SWELLING; CEREBROVASCULAR SURGERY; COGNITION; COGNITIVE DEFECT; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMISPHERE; MACROGLIA; MALE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SENSORIMOTOR FUNCTION; THREE DIMENSIONAL IMAGING;

ANIMAL BEHAVIOR; ASTROCYTES; DIABETES MELLITUS; METFORMIN; NEOVASCULARIZATION; RECOVERY; TYPE 2;

ANIMALS; BRAIN ISCHEMIA; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; RATS, WISTAR; RECOVERY OF FUNCTION; STROKE;

EID: 84888341499     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.113.001660     Document Type: Article

References (51)

1. Mukherjee D, Patil CG. Epidemiology and the global burden of stroke. World Neurosurg. 2011, 76(6 suppl):S85-S90.
2. Kim AS, Johnston SC. Global variation in the relative burden of stroke and ischemic heart disease. Circulation. 2011, 124:314-323.
3. Nannetti L, Paci M, Baccini M, Rinaldi LA, Taiti PG. Recovery from stroke in patients with diabetes mellitus. J Diabetes Complications. 2009, 23:249-254.
4. Jørgensen H, Nakayama H, Raaschou HO, Olsen TS. Stroke in patients with diabetes. The Copenhagen Stroke Study. Stroke. 1994, 25:1977-1984.
5. Khatri P, Wechsler LR, Broderick JP. Intracranial hemorrhage associated with revascularization therapies. Stroke. 2007, 38:431-440.
6. Mankovsky BN, Ziegler D. Stroke in patients with diabetes mellitus. Diabetes Metab Res Rev. 2004, 20:268-287.
7. Megherbi SE, Milan C, Minier D, Couvreur G, Osseby GV, Tilling K, et al, European BIOMED Study of Stroke Care Group. Association between diabetes and stroke subtype on survival and functional outcome 3 months after stroke: data from the European BIOMED Stroke Project. Stroke. 2003, 34:688-694.
8. Launer LJ, Miller ME, Williamson JD, Lazar RM, Gerstein HC, Murray AM, et al, ACCORD MIND investigators. Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): A randomised open-label substudy. Lancet Neurol. 2011, 10:969-977.
9. Saczynski JS, Jónsdóttir MK, Garcia ME, Jonsson PV, Peila R, Eiriksdottir G, et al. Cognitive impairment: An increasingly important complication of type 2 diabetes: The age, gene/environment susceptibility- Reykjavik study. Am J Epidemiol. 2008, 168:1132-1139.
10. Poels MM, Ikram MA, Vernooij MW, Krestin GP, Hofman A, Niessen WJ, et al. Total cerebral blood flow in relation to cognitive function: The Rotterdam Scan Study. J Cereb Blood Flow Metab. 2008, 28:1652-1655.
11. Elias MF, Elias PK, Sullivan LM, Wolf PA, D'Agostino RB. Obesity, diabetes and cognitive deficit: The Framingham Heart Study. Neurobiol Aging. 2005, 26(suppl 1):11-16.
12. Xiong Y, Mahmood A, Chopp M. Angiogenesis, neurogenesis and brain recovery of function following injury. Curr Opin Investig Drugs. 2010, 11:298-308.
13. Zhang ZG, Chopp M. Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinic. Lancet Neurol. 2009, 8:491-500.
14. Ergul A, Alhusban A, Fagan SC. Angiogenesis: A harmonized target for recovery after stroke. Stroke. 2012, 43:2270-2274.
15. Chopp M, Zhang ZG, Jiang Q. Neurogenesis, angiogenesis, and MRI indices of functional recovery from stroke. Stroke. 2007, 38(suppl 2):827-831.
16. Kelly-Cobbs AI, Prakash R, Coucha M, Knight RA, Li W, Ogbi SN, et al. Cerebral myogenic reactivity and blood flow in type 2 diabetic rats: role of peroxynitrite in hypoxia-mediated loss of myogenic tone. J Pharmacol Exp Ther. 2012, 342:407-415.
17. Prakash R, Somanath PR, El-Remessy AB, Kelly-Cobbs A, Stern JE, Dore-Duffy P, et al. Enhanced cerebral but not peripheral angiogenesis in the Goto-Kakizaki model of type 2 diabetes involves VEGF and peroxynitrite signaling. Diabetes. 2012, 61:1533-1542.
18. Li W, Prakash R, Kelly-Cobbs AI, Ogbi S, Kozak A, El-Remessy AB, et al. Adaptive cerebral neovascularization in a model of type 2 diabetes: relevance to focal cerebral ischemia. Diabetes. 2010, 59:228-235.
19. Ergul A, Li W, Elgebaly MM, Bruno A, Fagan SC. Hyperglycemia, diabetes and stroke: focus on the cerebrovasculature. Vascul Pharmacol. 2009, 51:44-49.
20. Sweetnam D, Holmes A, Tennant KA, Zamani A, Walle M, Jones P, et al. Diabetes impairs cortical plasticity and functional recovery following ischemic stroke. J Neurosci. 2012, 32:5132-5143.
21. Knoflach M, Matosevic B, Rücker M, Furtner M, Mair A, Wille G, et al, Austrian Stroke Unit Registry Collaborators. Functional recovery after ischemic stroke- A matter of age: data from the Austrian Stroke Unit Registry. Neurology. 2012, 78:279-285.
22. Liman TG, Heuschmann PU, Endres M, Flöel A, Schwab S, Kolominsky- Rabas PL. Changes in cognitive function over 3 years after first-ever stroke and predictors of cognitive impairment and long-term cognitive stability: The Erlangen Stroke Project. Dement Geriatr Cogn Disord. 2011, 31:291-299.
23. Morris DC, Yeich T, Khalighi MM, Soltanian-Zadeh H, Zhang ZG, Chopp M. Microvascular structure after embolic focal cerebral ischemia in the rat. Brain Res. 2003, 972:31-37.
24. Arai K, Jin G, Navaratna D, Lo EH. Brain angiogenesis in developmental and pathological processes: neurovascular injury and angiogenic recovery after stroke. FEBS J. 2009, 276:4644-4652.
25. Chopp M, Li Y, Zhang J. Plasticity and remodeling of brain. J Neurol Sci. 2008, 265:97-101.
26. Krupinski J, Kaluza J, Kumar P, Kumar S, Wang JM. Role of angiogenesis in patients with cerebral ischemic stroke. Stroke. 1994, 25:1794-1798.
27. Slevin M, Kumar P, Gaffney J, Kumar S, Krupinski J. Can angiogenesis be exploited to improve stroke outcome? Mechanisms and therapeutic potential. Clin Sci (Lond). 2006, 111:171-183.
28. Vannucci SJ, Willing LB, Goto S, Alkayed NJ, Brucklacher RM, Wood TL, et al. Experimental stroke in the female diabetic, db/db, mouse. J Cereb Blood Flow Metab. 2001, 21:52-60.
29. Schiekofer S, Galasso G, Sato K, Kraus BJ, Walsh K. Impaired revascularization in a mouse model of type 2 diabetes is associated with dysregulation of a complex angiogenic-regulatory network. Arterioscler Thromb Vasc Biol. 2005, 25:1603-1609.
30. Zhu M, Bi X, Jia Q, Shangguan S. The possible mechanism for impaired angiogenesis after transient focal ischemia in type 2 diabetic GK rats: different expressions of angiostatin and vascular endothelial growth factor. Biomed Pharmacother. 2010, 64:208-213.
31. Font MA, Arboix A, Krupinski J. Angiogenesis, neurogenesis and neuroplasticity in ischemic stroke. Curr Cardiol Rev. 2010, 6:238-244.
32. Hayward NM, Yanev P, Haapasalo A, Miettinen R, Hiltunen M, Gröhn O, et al. Chronic hyperperfusion and angiogenesis follow subacute hypoperfusion in the thalamus of rats with focal cerebral ischemia. J Cereb Blood Flow Metab. 2011, 31:1119-1132.
33. Lin TN, Sun SW, Cheung WM, Li F, Chang C. Dynamic changes in cerebral blood flow and angiogenesis after transient focal cerebral ischemia in rats. Evaluation with serial magnetic resonance imaging. Stroke. 2002, 33:2985-2991.
34. Mogoanta L, Pirici D, Pop OT, Balseanu AT, Rolea E, Dahnovici RM. Study of vascular microdensity in areas of cerebral ischemia on experimental model. Rom J Morphol Embryol. 2010, 51:725-731.
35. Busch SA, Silver J. The role of extracellular matrix in CNS regeneration. Curr Opin Neurobiol. 2007, 17:120-127.
36. Pannasch U, Vargová L, Reingruber J, Ezan P, Holcman D, Giaume C, et al. Astroglial networks scale synaptic activity and plasticity. Proc Natl Acad Sci USA. 2011, 108:8467-8472.
37. Nudo RJ, Plautz EJ, Frost SB. Role of adaptive plasticity in recovery of function after damage to motor cortex. Muscle Nerve. 2001, 24:1000-1019.
38. Dancause N, Barbay S, Frost SB, Plautz EJ, Chen D, Zoubina EV, et al. Extensive cortical rewiring after brain injury. J Neurosci. 2005, 25:10167-10179.
39. Jefferson AL, Massaro JM, Beiser AS, Seshadri S, Larson MG, Wolf PA, et al. Inflammatory markers and neuropsychological functioning: The Framingham Heart Study. Neuroepidemiology. 2011, 37:21-30.
40. van Dijk EJ, Prins ND, Vrooman HA, Hofman A, Koudstaal PJ, Breteler MM. Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences: Rotterdam Scan study. Stroke. 2008, 39:2712-2719.
41. Elias PK, Elias MF, D'Agostino RB, Cupples LA, Wilson PW, Silbershatz H, et al. NIDDM and blood pressure as risk factors for poor cognitive performance. The Framingham Study. Diabetes Care. 1997, 20:1388-1395.
42. Elgebaly MM, Prakash R, Li W, Ogbi S, Johnson MH, Mezzetti EM, et al. Vascular protection in diabetic stroke: role of matrix metalloprotease- dependent vascular remodeling. J Cereb Blood Flow Metab. 2010, 30:1928-1938.
43. Duckworth WC. Hyperglycemia and cardiovascular disease. Curr Atheroscler Rep. 2001, 3:383-391.
44. Lund SS, Tarnow L, Stehouwer CD, Schalkwijk CG, Teerlink T, Gram J, et al. Impact of metformin versus repaglinide on non-glycaemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non-obese patients with type 2 diabetes. Eur J Endocrinol. 2008, 158:631-641.
45. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000, 321:405-412.
46. UK Prospective Diabetes Study (UKPDS) group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998, 352:854-865.
47. Schernthaner G. Diabetes and Cardiovascular Disease: is intensive glucose control beneficial or deadly? Wien Med Wochenschr. 2010, 160:8-19.
48. Laakso M. Hyperglycemia and cardiovascular disease in type 2 diabetes. Diabetes. 1999, 48:937-942.
49. Gaede P. Intensive glucose control and cardiovascular disease in type 2 diabetes-should we change the recommended target for glycated hemoglobin? Pol Arch Med Wewn. 2008, 118:619-621.
50. Faure P, Wiernsperger N, Polge C, Favier A, Halimi S. Impairment of the antioxidant properties of serum albumin in patients with diabetes: protective effects of metformin. Clin Sci (Lond). 2008, 114:251-256.
51. Rösen P, Wiernsperger NF. Metformin delays the manifestation of diabetes and vascular dysfunction in Goto-Kakizaki rats by reduction of mitochondrial oxidative stress. Diabetes Metab Res Rev. 2006, 22:323-330.